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Introduction
In the posterior maxilla, insufficient bone volume is frequently encountered due to the pneumatisation of the maxillary sinus together with crestal bone resorption after tooth loss. 1 This can hinder dental implant placement in this region. Maxillary sinus floor elevation (SFE) is a widely used surgical procedure for regaining adequate bone height before implant placement. Commonly, the sinus floor is augmented with autogenous bone or biomaterials or a combination of both. 1 Autogenous bone has long been considered the gold standard grafting material because of its osteoinductive and osteoconductive properties. In general, bone substitutes have no osteoinductive potential but are considered to provide a scaffold for optimal bone growth. 2 In a recent literature review, different materials used in SFE procedures were examined. 1 It was noted that intra-oral donor sites are convenient but yield limited volume. Extra-oral donor sites increase surgical complexity and are associated with significant (and underreported) morbidity and scarring. 1 Therefore alternative grafting materials have been developed.
Because of the human and animal origin of allografts and xenografts, alloplasts are alternatively used. 3 Of those alloplasts, calcium phosphate bioceramics, e.g. hydroxyapatite granules show a rough surface leading to a porous structure ranging from micrometer to millimeter in dimension. An animal study showed a significantly better biological behavior of the new high-porous bone replacement material (NanoBone ® ) in comparison with the conventionally sintered ceramics . 7 Furthermore, the authors noted that bone formation and resorption rates after implantation of the nano-cristalline HA were higher compared with other commercial available HAs, TCPs, or gelatine sponges (control group). Other studies revealed signs of osteoconduction as well as osteoinduction in the histological and immunohistochemical investigations of human and animal biopsies. 4, 7, 8 Additionally, high levels of biocompatibility and angiogenic response were reported. 9 In recent histological investigations of human biopsies from sinus augmentations using the nanocristalline HA, newly formed bone although in limited quantities was already found at 3 months of healing, 10, 11 and new trabecular bone was found at 6 months of healing. 10, 12 Well-mineralized regenerated bone with lamellar parallel-fibred structure and Haversian systems surrounded the residual NanoBone ® particles. 11 Moreover, it was observed that NanoBone ® has osteoconductive and biomimetic properties and is integrated into the host's physiological bone turnover at a very early stage. 4 Clinical and radiographic outcomes of sinus grafts have been studied. [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] Of particular interest is whether graft height and volume are maintained over the long term. A clinical study was conducted to evaluate the factors affecting changes in sinus graft height between and above implants. 23 It concluded that the type of the grafting material is the main factor affecting changes in height.
Therefore, the first aim of the present prospective study was to evaluate the vertical shrinkage percentage of nano-crystalline HA embedded in silica gel (NanoBone ® ), twelve months after maxillary SFE and before implant placement. The second aim of the study was to determine the survival rate of the implants at one-year post placement in the healed grafted sinuses.
Materials and methods

Patient selection
Between women and 3 men with a mean age of 53 years (range 37-65 years).
Surgical procedures
The surgical procedures were carried out under local anesthesia (Ubistesin TM , 3M ESPE AG, Germany) by either one of three experienced surgeons. All patients received perioperative antibiotic prophylaxis with Clindamycine (Dalacin ® C; Pfizer SA, Zürich, Switzerland) 3 x 300 mg/day for 5 days, starting with 2 x 300 mg, 1 h before surgery.
Maxillary SFE
A mucoperiosteal flap was elevated after a crestal incision and two vertical releasing incisions were performed to expose the lateral wall of the sinus. A lateral bony window was outlined and completely removed with a 3 mm diameter round diamond bur. The
Schneiderian membrane was carefully reflected, a bioresorbable porcine collagen membrane (Bio-Gide ® , Geistlich Pharma AG, Switzerland) was placed along it, and the space was filled with 0.6 ml to 2.4 ml of 0.6 mm granules of NanoBone 
Implant insertion
After an average healing period of 14.42 months (±3.69), transmucosal Straumann ® implants (Institute Straumann AG, Basel, Switzerland) were placed. Implant bed preparations and biopsies were realized in the grafted area using a trephine drill with an external diameter of 
Survival criteria
Implant survival was assessed at the 1-year control following the criteria proposed by Buser et al. 25 and Cochran et al. 26 These criteria included the following: (1) absence of clinically detectable implant mobility, (2) absence of pain or any subjective sensation, (3) absence of recurrent peri-implant infection and (4) absence of continuous radiolucency around the implant.
Radiographic analysis
The aim of the radiographic analysis was to evaluate the post augmentation graft shrinkage percentage. During the follow-up period, at least four radiographic examinations were made in each patient. For the grafted volume evaluation, panoramic radiographs were taken immediately after surgery (T0s) and 12 months (range 11.3 -13.3 months) after surgery (T1s).
All the panoramic radiographs were taken using a Scanora 
Image processing
The following digital procedures were applied to all examined radiographs. Image mode was set to grayscale and 8 Bits / Channel. Both the T0s and T1s panoramic radiographs were copied on a single .psd file and separated as two layers. The region of interest (ROI) was then outlined on each radiograph using the crop tool. It was defined as follows: mesially, two neighboring teeth to the grafted sinus; distally, a vertical line passing 2 mm beyond the maxillary tuberosity; crestally, the occlusal plane of the neighboring teeth; apically, a horizontal line passing 1 cm above the grafted sinus floor (Fig. 1) . The two layers were only then superposed and equalized in order to discard grayscale variation outside the ROI. The superposition was done following the anterior and posterior sinus walls, the neighboring teeth and the maxillary tuberosity (Fig. 2, a) .
Measurements
Three horizontal lines were set on the T0s and T1s layers. The first two lines were set on layer T0s, one passing through the highest point of the crestal bone (CB) and the other passing through the highest point of the augmented floor (AF0) (Fig. 2, b) . The third line was set on layer T1s, passing through the highest point of the actual augmented floor (AF1) (Fig. 2, c) .
The T0s and T1s layers being superposed, measurement of the distance in pixels between CB and AF0 (AF0d) and CB and AF1 (AF1d) were taken with the ruler tool (Fig. 2, d ). The ratio AF1d/AF0d was then calculated for each SFE case. A ratio value less than 1.0 indicates that the grafted sinus floor is more cervically positioned at T1s than at T0s, and that the graft shrank during this period. The graft shrinkage percentage was obtained by multiplying the ratio by 100.
Results
Eleven SFE procedures were conducted in eight patients. A total of nineteen implants were placed in 10 sinuses. Of those nineteen implants, 17 implants were placed in distally shortened arches, and 2 implants in single tooth gaps. Four implants were rehabilitated with single crowns, 13 implants were rehabilitated with splinted crowns and one implant was rehabilitated with a tooth-to-implant fixed partial denture. Implant length was 10 mm in all the cases (Table 1) .
Complications and morbidity
During the SFE procedures, no macroscopic perforation of the sinus membrane was noted in any of the cases. Two postoperative wound infections occurred after the augmentation procedures. In the first case, painful swelling of the posterior maxillary area appeared 7
weeks after augmentation and was treated with Clindamycin (Dalacin ® C; Pfizer SA, Zürich, Switzerland) at 300 mg 3 times daily for 5 days and local irrigation with 3% hydrogen peroxide (H2O2). Nonetheless, residual swelling remained for 6 months with no painful symptomatology. During surgical re-entry, a macroscopic perforation surrounded by granulation tissue was noted and re-augmentation was conducted. Implant insertion took place 8 months later. Consequently, this case was excluded from the study. In the second case, the patient also complained of painful swelling at the surgical area 3 weeks after sinus augmentation. The infectious incident was treated with Clindamycin (Dalacin ® C; Pfizer SA, Zürich, Switzerland) at 300 mg 3 times daily for 5 days and local irrigation with 3% hydrogen peroxide (H2O2). The infection being successfully treated, two implants were placed 10 months later. Radiographic control 4 months after implant placement revealed that one of the implants (site 26) had migrated apically. Re-entry was conducted for the removal of the failed implant. No implant replacement was scheduled, and a tooth-to-implant fixed partial denture was made.
Radiographic analysis
The mean graft height shrinkage percentage at 12 months (range 11.3 -13.3 months) after surgery was 8.84% (± 5.32) ( Table 2) .
Implant survival
Of 19 placed implants, 18 survived ( Table 3 ). The cumulative survival rate at the one-year interval was 94.74%. All 18 implants received the prosthetic rehabilitation and were controlled after 3 months of functional loading.
Discussion
Various radiographic methods were used to assess the position of the maxillary sinus floor.
Most authors used panoramic radiographs. 13 22 However, the same authors state that this is a more expensive radiographic technique that considerably increases the level of radiation for the patient. The dose given to patients with a CT-scan is evaluated as roughly 150-300 times that of a panoramic radiograph. 27, 29 On the other hand, panoramic radiographs can be used for bone height measurements but do not allow for volume measurements. 21 Consequently, bone height measurement with panoramic radiographs has been conducted in this study to evaluate graft height shrinkage. This technique seemed sufficient since no three-dimensional volume evaluation was sought.
Radiographic evaluation of graft height changes after maxillary SFE was addressed in the literature through a few short-term studies 15, 17 and some long-term studies. 13, 14, 16, [18] [19] [20] [21] [22] [23] [24] In a study including a total of 191 patients who underwent maxillary SFE and were radiographically followed for up to about 10 years, it was noted that the ratio of grafted sinus height to original sinus height (GSH/OSH) significantly decreased between 0-6 months and 7-12 months, displaying no significant change thereafter. 19 A study compared the vertical dimensional changes regarding graft height with a long-term follow-up of at least 4.5 years, in patients treated with two different grafting materials used in maxillary SFE procedures. 21 The authors noted that after an initial height reduction in the first 1.5 year, subsequent changes were minimal. They added that most shrinkage took place in the first time period (< 7.5 months). Another study showed that after a mean vertical bone loss of 1.3 mm during the first year post grafting, only minimal loss was observed during the second and the third year. 18 In this study, the aim was to evaluate the graft shrinkage percentage relative to the specific grafting material, in the absence of implants. The literature shows that graft shrinkage takes place mainly in the first year, thus the 12-months timeframe set for this study seemed justifiable.
In a study, 23 the authors reviewed different published data [15] [16] [17] [18] 21, 23 and calculated the corresponding shrinkage percentages of several graft types. A shrinkage percentage of 48%
was noted during the first 6 months when autogenous bone was used for maxillary SFE.
12.7% between the implants) 23 . In the present study, our main objective was to determine the height shrinkage percentage of 100% NanoBone ® alloplastic graft used for maxillary SFE.
Our results show that the estimated mean graft height shrinkage percentage (8.84% ± 5.32)
corresponds to the values cited in the literature. Thus, the material seems to maintain its volume in the first critical year of bone remodeling.
Two trials were conducted to evaluate whether autogenous bone could be replaced by bone substitutes to reduce surgical morbidity. 30, 31 It is suggested that autogenous bone can be substituted with 80% (mixed with autogenous bone) to 100% BHA when used for maxillary SFE. 30 Results from the same study indicate that similar short-term results can be expected when using autogenous bone, BHA, or a mixture of both for maxillary SFE and delayed placement of dental implants. In a recent review, it is acknowledged that autogenous bone might be replaced by bone substitutes for SFE, however the authors advise that larger trials with longer follow-up should be conducted to validate these preliminary findings.
1 Accordingly, our study protocol consisted of using 100% NanoBone ® for maxillary SFE with residual bone heights ≤ 3 mm. Implants were then mainly placed in augmented volumes with minimal native crestal bone. Apart from the excluded case where persistent infection could be attributed to an undetected sinus membrane perforation during the initial SFE noted on surgical re-entry, our short-term results showed that 100% NanoBone ® could replace autogenous bone in staged maxillary SFE procedures.
Implant survival rates similar to the results in this study have been reported in the literature when rough-surfaced implants are placed following staged SFE procedures. A review aimed to evaluate implant survival rates in the grafted sinus versus survival rates of implants placed in the non-grafted posterior maxilla. 32 Results showed that the survival rate of implants placed in sinuses augmented with the lateral window technique varied between 61.7% and 100%, with an average survival rate of 91.8%. Rough-surfaced implants showed a higher survival rate than machine-surfaced implants when placed in grafted sinuses. In another review, 33 the authors evaluated implant survival rates in the grafted sinus taking into account the influence of the implant surface, graft material, and implant placement timing. Results
showed that machine-surfaced implants placed in the grafted maxillary sinus displayed a mean survival rate of 85.64%, and rough-surfaced implants exhibited a mean survival rate of 95.98%. 34 A prospective study evaluated the 5-year performance and success rate of implants with titanium plasma spray (TPS) or sand-blasted, large grit, acid-etched (SLA) surface inserted in a two-stage maxillary SFE procedure. 34 All 98 implants were considered successfully integrated, resulting in a 5-year success rate of 98% (for TPS implants 89%, for SLA implants 100%). Another review stated that, independently of the graft material used for lateral SFE, a mean survival rate of 86.3% was noted for machine-surfaced implants compared to 96.7% for rough-surfaced implants. 2 In the present study, implant apical migration and its subsequent failure could be explained by an extended implant bed preparation beyond the augmented sinus floor. Consequently, the implant survival rate (94.74%) obtained in the present study is consistent with published results reported for rough-surfaced implants placed in grafted sinuses. Furthermore, it can be concluded that NanoBone ® in a 100% ratio could provide a viable augmented bone volume for implant placement with a short-term survival rate in accordance with published data.
Conclusions
The present 1-year prospective study indicates that a 100% NanoBone ® alloplastic graft used in lateral SFE procedures presented limited height shrinkage. Implants placed in these grafted sinuses showed survival rates similar to that found in published data. These results should be interpreted cautiously considering the study's reduced sample size. 
